FDA Approves Spectranetics' Stellarex Drug-Coated Balloon - Medical Product Outsourcing
PDF) Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies
Philips Fulfills a Prophecy with $2.2B Spectranetics Deal | mddionline.com
Video : Live Case #12: PAOD CTO atherectomy + Stellarex® (Philips)
Latest data from Philips reinforces the safety profile of Stellarex low-dose DCB - Vascular News
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons » Cardiology2.0
Stellarex | The Clear DCB Choice
FDA approves Philips' low-dose Stellarex balloons - Drug Delivery Business
Stellarex Drug Coated Angioplasty Balloons – Vascupedia